NIPRO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,262 JPY | +0.44% |
|
+2.39% | +14.05% |
| Apr. 12 | Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold | MT |
| Jan. 11 | Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold | MT |
| Sales 2024 * | 592B 3.82B | Sales 2025 * | 627B 4.05B | Capitalization | 205B 1.32B |
|---|---|---|---|---|---|
| Net income 2024 * | 15.14B 97.65M | Net income 2025 * | 16.94B 109M | EV / Sales 2024 * | 1.2 x |
| Net Debt 2024 * | 507B 3.27B | Net Debt 2025 * | 511B 3.3B | EV / Sales 2025 * | 1.14 x |
| P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
12.1
x | Employees | 38,770 |
| Yield 2024 * |
2.65% | Yield 2025 * |
3% | Free-Float | 83.71% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.44% | ||
| 1 week | +2.39% | ||
| Current month | +3.02% | ||
| 1 month | +5.38% | ||
| 3 months | +6.63% | ||
| 6 months | +12.62% | ||
| Current year | +14.05% |
1 week
1 213.00
1 269.00
1 month
1 189.501 302.50
Current year
1 094.001 302.50
1 year
987.001 302.50
3 years
987.001 398.00
5 years
908.001 547.00
10 years
828.001 752.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yoshihiko Sano
PSD | President | 79 | 75-10-31 |
Masanobu Iwasa
ADM | Chief Administrative Officer | 65 | 82-03-31 |
Mitsutaka Ueda
BRD | Director/Board Member | 68 | 76-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kimihito Minoura
BRD | Director/Board Member | 51 | 95-03-31 |
Goichi Miyazumi
BRD | Director/Board Member | - | - |
Toshiaki Masuda
BRD | Director/Board Member | 71 | 75-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.17% | 31 M€ | +12.22% | ||
| 0.03% | 18 M€ | +16.15% | - | |
| 0.03% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 1,262 | +0.44% | 435 100 |
| 24-04-23 | 1,257 | -0.08% | 362,500 |
| 24-04-22 | 1,258 | +1.90% | 366,300 |
| 24-04-19 | 1,234 | -0.80% | 543,400 |
| 24-04-18 | 1,244 | +0.93% | 514,200 |
Delayed Quote Japan Exchange, April 24, 2024 at 02:00 am EDT
More quotes
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Calendar
2024-05-09
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,257
JPY
Average target price
1,475
JPY
Spread / Average Target
+17.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.05% | 1.32B | |
| -2.25% | 187B | |
| -1.32% | 108B | |
| -3.92% | 67.71B | |
| +7.99% | 53.07B | |
| +15.74% | 47.36B | |
| +6.01% | 39.73B | |
| +10.81% | 28.56B | |
| +2.34% | 26.55B | |
| +15.97% | 25.13B |
- Stock Market
- Equities
- 8086 Stock
